出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年 1月
アジア太平洋地域の空間ゲノミクスおよびトランスクリプトミクス市場 : 技術［空間トランスクリプトミクス（IHC、ISH）、空間ゲノミクス（FISH、シーケンシング）］、製品（機器、消耗品、ソフトウェア）、用途（創薬）、エンドユーザー（バイオテクノロジー、CRO） – 2027年までの予測
APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) – Forecast to 2027
| ページ数 | 145 |
| 図表数 | 121 |
| 種別 | 英文調査報告書 |
| 価格 |
The Asia Pacific spatial genomics and transcriptomics market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period.
The key factors driving the growth of the spatial genomics and transcriptomics market in the Asia Pacific are growing number of consumables for various spatial genomics and transcriptomics applications, introduction of novel products, and increasing adoption of spatial genomics & transcriptomics in drug discovery & development. However, the high capital investments associated with spatial genomics and transcriptomics are expected to restrain market growth to a certain extent.
The Asia Pacific spatial genomics and transcriptomics market has been segmented based on product, technique, application, end user, and country.
“By application, the translational research accounted for the largest share of the Asia Pacific spatial genomics & transcriptomics market”
Based on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery & development. The translation research segment dominated the market in 2021, owing to increasing research grants and funding by government and non-government organizations.
“By technique, the spatial transcriptomics accounted for the largest share in the Asia Pacific spatial genomics & transcriptomics market”
Based on technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics and spatial genomics analysis. In 2021, the spatial transcriptomics segment accounted for a larger share of the Asia Pacific spatial genomics and transcriptomics market. Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.
“China: the largest share of the spatial genomics & transcriptomics market”
China accounted for the largest share of the spatial genomics & transcriptomics market. Factors such as rising incidence of chronic diseases, increasing research funding by the government and biopharma companies for the development of new regenerative medicine are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: Executives – 40%, Research Scientists- 30%, and Managers – 30%
• By Country: Japan- 22%, China- 47%, India- 11%, Rest of APAC- 20%
Prominent Players
• NanoString Technologies, Inc. (US)
• 10X Genomics (US)
• Illumina (US)
• Bio-Rad Laboratories (US)
• Bio-Techne Corporation (US)
• Standard BioTools Inc. (US)
• Genomic Vision SA (France)
• Akoya Biosciences, Inc. (US)
• S2 Genomics (US)
• Cantata Bio (US)
• Vizgen Group (US)
• BGI Group (China)
• Miltenyi Biotec (Germany)
• Bruker (US)
• Perkinelmer Inc. (US)
• Novogene Co., Ltd. (China)
Research Coverage:
This report provides a detailed picture of the spatial genomics & trancriptomics market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, technology, applications, end user, and country. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
目次
1 INTRODUCTION 14
1.1 STUDY OBJECTIVES 14
1.2 MARKET DEFINITION 14
1.2.1 INCLUSIONS AND EXCLUSIONS 14
1.3 STUDY SCOPE 15
1.4 YEARS CONSIDERED 15
1.5 CURRENCY CONSIDERED 16
1.6 LIMITATIONS 16
1.7 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
FIGURE 1 RESEARCH DESIGN 17
2.1.1 SECONDARY DATA 18
2.1.2 PRIMARY DATA 19
FIGURE 2 BREAKDOWN OF PRIMARIES: ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET 19
2.2 MARKET ESTIMATION METHODOLOGY 20
FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) 20
FIGURE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SIZE (USD MILLION) 20
FIGURE 5 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022−2027) 21
FIGURE 6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 21
2.3 MARKET DATA ESTIMATION AND TRIANGULATION 22
FIGURE 7 DATA TRIANGULATION METHODOLOGY 22
2.4 INDUSTRY INSIGHTS 23
2.5 RESEARCH ASSUMPTIONS 23
3 EXECUTIVE SUMMARY 24
FIGURE 8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 24
FIGURE 9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 25
FIGURE 10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 25
FIGURE 11 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 26
FIGURE 12 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY COUNTRY, 2021 27
4 PREMIUM INSIGHTS 28
4.1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW 28
FIGURE 13 REDUCED COST OF NEXT-GENERATION SEQUENCING TO DRIVE MARKET GROWTH 28
4.2 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT (2021) 29
FIGURE 14 CONSUMABLES SEGMENT DOMINATED MARKET IN JAPAN 29
4.3 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION (2021) 29
FIGURE 15 TRANSLATIONAL RESEARCH SEGMENT DOMINATED MARKET IN CHINA 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
FIGURE 16 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30
TABLE 1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS 31
5.2.1 DRIVERS 31
5.2.1.1 Reduced cost of next-generation sequencing 31
5.2.1.2 Increasing adoption of spatial genomics and transcriptomics in drug discovery and development 32
5.2.2 RESTRAINTS 32
5.2.2.1 High capital investments 32
5.2.3 OPPORTUNITIES 32
5.2.3.1 Increasing demand for single-cell analysis 32
5.2.4 CHALLENGES 33
5.2.4.1 Analytical limitations associated with spatial techniques 33
5.3 TECHNOLOGY ANALYSIS 33
TABLE 2 FIVE BENCHMARK COMPUTATIONAL METHODS: COMPARATIVE ANALYSIS 34
5.4 VALUE CHAIN ANALYSIS 35
TABLE 3 INDICATIVE LIST OF DISTRIBUTORS FOR KEY MARKET PLAYERS IN ASIA PACIFIC 35
FIGURE 17 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS 36
5.5 ECOSYSTEM ANALYSIS 36
FIGURE 18 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS 37
5.6 PORTER’S FIVE FORCES ANALYSIS 37
TABLE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS 37
5.6.1 THREAT OF NEW ENTRANTS 37
5.6.2 THREAT OF SUBSTITUTES 37
5.6.3 BARGAINING POWER OF BUYERS 38
5.6.4 BARGAINING POWER OF SUPPLIERS 38
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 38
5.7 REGULATORY ANALYSIS 38
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 38
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 38
5.8 PRICING ANALYSIS 39
TABLE 6 PRODUCT PRICING: KEY MARKET PLAYERS 39
5.8.1 AVERAGE SELLING PRICE TREND 39
5.9 KEY CONFERENCES AND EVENTS (2020–2023) 39
TABLE 7 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2020–2023) 39
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 40
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 40
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 40
5.10.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET IN ASIA PACIFIC REGION 40
FIGURE 20 KEY BUYING CRITERIA FOR END USERS 40
6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY PRODUCT 41
6.1 INTRODUCTION 42
TABLE 8 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 42
6.2 CONSUMABLES 42
6.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE GROWTH 42
TABLE 9 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 43
6.3 INSTRUMENTS 43
6.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET 43
TABLE 10 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 44
6.4 SOFTWARE 44
6.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE 44
TABLE 11 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 45
7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE 46
7.1 INTRODUCTION 47
TABLE 12 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 47
7.2 SPATIAL TRANSCRIPTOMICS 47
TABLE 13 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 47
TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 48
7.2.1 IMMUNOHISTOCHEMISTRY 48
7.2.1.1 Emergence of mIHC/IF to propel growth 48
TABLE 15 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 49
7.2.2 IN SITU HYBRIDIZATION 49
7.2.2.1 High adoption of MERFISH to drive growth 49
TABLE 16 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 50
7.2.3 SPATIAL TRANSCRIPTOMIC SEQUENCING 50
TABLE 17 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 50
7.2.3.1 Microdissection-based sequencing 51
7.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth 51
TABLE 18 ASIA PACIFIC: MICRODISSECTION-BASED SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 51
7.2.3.2 In situ sequencing 52
7.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth 52
TABLE 19 ASIA PACIFIC: IN SITU SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 52
7.2.3.3 Other sequencing technologies 53
TABLE 20 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION) 53
7.2.4 MICROSCOPY-BASED RNA IMAGING 53
7.2.4.1 Increasing use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth 53
TABLE 21 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 54
7.2.5 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES 54
TABLE 22 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION) 54
7.3 SPATIAL GENOMICS ANALYSIS 55
TABLE 23 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 55
TABLE 24 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 55
7.3.1 FLUORESCENCE IN SITU HYBRIDIZATION 56
7.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support growth 56
TABLE 25 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 56
7.3.2 SPATIAL GENOMIC SEQUENCING 56
7.3.2.1 Rising adoption of massively parallel sequencing to drive growth 56
TABLE 26 ASIA PACIFIC: SPATIAL GENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 57
7.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES 57
TABLE 27 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 57
8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY APPLICATION 58
8.1 INTRODUCTION 59
TABLE 28 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59
8.2 TRANSLATIONAL RESEARCH 59
8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE GROWTH 59
TABLE 29 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 60
8.3 DRUG DISCOVERY AND DEVELOPMENT 60
8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE GROWTH 60
TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 61
9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY END USER 62
9.1 INTRODUCTION 63
TABLE 31 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 63
9.2 ACADEMIC AND RESEARCH INSTITUTES 63
9.2.1 INCREASING DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH 63
TABLE 32 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 64
9.3 CONTRACT RESEARCH ORGANIZATIONS 64
9.3.1 INCREASING NUMBER OF CROS FORMING STRATEGIC PARTNERSHIPS WITH GENOMICS PROVIDERS TO DRIVE GROWTH 64
TABLE 33 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 65
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 65
9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS SYSTEMS 65
TABLE 34 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 66
10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY COUNTRY 67
10.1 INTRODUCTION 68
TABLE 35 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 68
10.2 CHINA 68
10.2.1 INCREASING R&D SPENDING BY GOVERNMENT AND BIOPHARMA COMPANIES TO SUPPORT MARKET GROWTH 68
TABLE 36 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 69
TABLE 37 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 38 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 39 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 70
TABLE 40 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70
TABLE 41 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 70
10.3 JAPAN 71
10.3.1 RISING FUNDING IN JAPAN TO BOOST RESEARCH APPLICATIONS 71
TABLE 42 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 71
TABLE 43 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 44 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 45 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 72
TABLE 46 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72
TABLE 47 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 73
10.4 INDIA 73
10.4.1 COLLABORATIONS BETWEEN HOSPITALS AND DIAGNOSTIC CENTERS FOR LABORATORY SERVICES TO BOOST GROWTH 73
TABLE 48 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 73
TABLE 49 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 50 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 51 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 74
TABLE 52 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75
TABLE 53 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 75
10.4.2 SINGAPORE 75
10.4.2.1 Active partnerships with key players to boost market growth 75
TABLE 54 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 76
TABLE 55 SINGAPORE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 56 SINGAPORE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 77
TABLE 57 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 77
TABLE 58 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77
TABLE 59 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 78
10.4.3 SOUTH KOREA 78
10.4.3.1 Government initiatives and strong R&D expenditure to propel demand for spatial solutions 78
TABLE 60 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 78
TABLE 61 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 62 SOUTH KOREA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 63 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 80
TABLE 64 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80
TABLE 65 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 80
10.4.4 AUSTRALIA 81
10.4.4.1 Increasing adoption of spatial solutions by research institutions to propel growth 81
TABLE 66 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 81
TABLE 67 AUSTRALIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 82
TABLE 68 AUSTRALIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 82
TABLE 69 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 83
TABLE 70 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83
TABLE 71 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 83
10.4.5 REST OF ASIA PACIFIC 84
TABLE 72 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 84
TABLE 73 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 74 REST OF ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 85
TABLE 75 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85
TABLE 76 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 85
TABLE 77 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 86
11 COMPETITIVE LANDSCAPE 87
11.1 INTRODUCTION 87
11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS 87
FIGURE 21 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 88
11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS) 89
11.4 MARKET SHARE ANALYSIS (2021) 89
11.5 COMPANY EVALUATION MATRIX 91
11.5.1 STARS 91
11.5.2 EMERGING LEADERS 91
11.5.3 PERVASIVE PLAYERS 91
11.5.4 PARTICIPANTS 91
FIGURE 24 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (2021) 92
11.6 COMPETITIVE SCENARIO AND TRENDS 93
11.6.1 DEALS 93
TABLE 78 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DEALS 93
11.6.1.1 Product launches 94
TABLE 79 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES 94
11.6.1.2 Other developments 94
TABLE 80 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS 94
12 COMPANY PROFILES 95
12.1 KEY PLAYERS 95
(Business Overview, Products, Recent Developments, MnM View)*
12.1.1 NANOSTRING 95
TABLE 81 NANOSTRING: BUSINESS OVERVIEW 95
FIGURE 25 NANOSTRING: COMPANY SNAPSHOT (2021) 96
12.1.2 10X GENOMICS 101
TABLE 82 10X GENOMICS: BUSINESS OVERVIEW 101
FIGURE 26 10X GENOMICS: COMPANY SNAPSHOT (2021) 102
12.1.3 ILLUMINA 105
TABLE 83 ILLUMINA: BUSINESS OVERVIEW 105
FIGURE 27 ILLUMINA: COMPANY SNAPSHOT (2021) 106
12.1.4 BIO-RAD LABORATORIES, INC. 111
TABLE 84 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 111
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 112
12.1.5 BIO-TECHNE 114
TABLE 85 BIO-TECHNE: BUSINESS OVERVIEW 114
FIGURE 29 BIO-TECHNE: COMPANY SNAPSHOT (2021) 115
12.1.6 STANDARD BIOTOOLS 120
TABLE 86 STANDARD BIOTOOLS: BUSINESS OVERVIEW 120
FIGURE 30 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021) 121
12.1.7 AKOYA BIOSCIENCES 127
TABLE 87 AKOYA BIOSCIENCES: BUSINESS OVERVIEW 127
FIGURE 31 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021) 127
12.1.8 S2 GENOMICS 131
TABLE 88 S2 GENOMICS: BUSINESS OVERVIEW 131
12.1.9 CANTATA BIO 132
TABLE 89 CANTATA BIO: BUSINESS OVERVIEW 132
12.1.10 VIZGEN CORP. 133
TABLE 90 VIZGEN: BUSINESS OVERVIEW 133
*Details on Business Overview, Products, Recent Developments, MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 134
12.2.1 BGI GROUP 134
12.2.2 MILTENYI BIOTEC 134
12.2.3 BRUKER 135
12.2.4 PERKINELMER INC. 135
12.2.5 NOVOGENE CO., LTD. 136
13 APPENDIX 137
13.1 DISCUSSION GUIDE 137
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 140
13.3 CUSTOMIZATION OPTIONS 142
13.4 RELATED REPORTS 142
13.5 AUTHOR DETAILS 143